Archives of Pharmacal Research

, Volume 18, Issue 2, pp 113–117 | Cite as

Preparation of δ-opioid receptor-specific antibodies using molecular cloned genes

  • Ae-Young Kim
  • Shee-Yong Lee
  • Kyeong-Man Kim
Research Articles

Abstract

We re-cloned mouse δ-opioid receptor from NG108-15 cells using RT-PCR, and confirmed it by restriction analysis and by sequencing the beginning and end part of the amplified DNA. When transiently expressed in COS-7 cells, cloned δ-opioid receptor showed saturable and specific binding to [3H]naloxone with very similar binding parameters to originally reported ones. To make antibodies specific for the δ-opioid receptor, the carboxy tail of the δ-opioid receptor, which is unique to the δ-opioid receptor compared with other opioid receptors, was expressed in bacteria as a fusion proteinwith glutathione S-transferase. Purified fusion protein was injected into rabbits to produce antibodies. The antibodies produced were highly selective for δ-opioid receptor when tested by western blotting using membrane proteins prepared from transfected COS-7 cells. Cloned δ-opioid receptor and antibodies specific for δ-opioid receptor are going to be valuable tools for studying pharmacological actions of the δ-opioid receptor and morphine dependence.

Key words

δ-Opioid receptor Antibodies Cloning Binding study 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abdelhamid, E. E., Sultana, M., Portoghese, P. S. and Takemori, A. E., Selective blockade of delta opioid receptor prevents the development of morphine tolerance and dependence in mice.J. Pharmacol. Exp. Ther. 258, 299–303 (1991).PubMedGoogle Scholar
  2. Bickel, W. K., Stitzer, M. L., Liebson, I. A. and Bigelow, G. E., Acute physical dependence in man: Effects of naloxone after brief morphine exposure.J. Pharmacol. Exp. Ther. 234, 126–132 (1988).Google Scholar
  3. Brase, D. A., Is intracellular sodium involved in the mechanism of tolerance to opioid drugs?Medical Hypotheses 32(3), 161–167 (1990).PubMedCrossRefGoogle Scholar
  4. Chen, Y., Mestek, A., Liu, J., Hurley, J. A. and Yu, L., Molecular cloning and functional expression of mopioid receptor from rat brain.Mol. Pharmacol., 44, 8–12 (1993).PubMedGoogle Scholar
  5. Childers, S. R., Opioid receptor-coupled second messenger systems,Life Sci., 48 (21), 1991–2003 (1991).PubMedCrossRefGoogle Scholar
  6. Collin, E. and Cesselin, F., Neurobiological mechanism of opioid tolerance and dependence.Clinic. Neuropharmacol. 14 (6), 465–488 (1991).CrossRefGoogle Scholar
  7. Evans, C. J., Keith, D. E., Jr., Morrison, H., Magendzo, K. and Edwards, R. H., Cloning of delta opioid receptor by functional expression.Science 258, 1952–1955 (1992).PubMedCrossRefGoogle Scholar
  8. Frankhuijzen, A. L., Wardeh, G. W., Mulder, A. H. and Schoffelmneer, A. N. M., Non-competitive interaction between mu and delta-opioid receptor binding sites in homogenates from the rat neocortex.Eur. J. Pharmacol. 183, 2307 (1990).CrossRefGoogle Scholar
  9. Fukuda, K., Kato, S., Mori, K., Nishi, M. and Takeshima, H., Primary structures and expression from cDNAs of rat opioid receptor δ-and κ-subtypes.FASEB letter 3, 311–314 (1993).CrossRefGoogle Scholar
  10. Holiday, J. W., Long, J. B. and Tortella, F. C., Evidence for μ κ, and δ-opioid binding site interactions in vivo.Fed. Proc. 44, 2860–2862 (1985).Google Scholar
  11. Jiang, Q., Mosberg, H. I. and Prorreca, F., Modulation of the potency and efficacy of mu-mediated antinociception by delta agonists in the mouse.J. Pharmacol. Exp. Ther., 254, 683–689 (1990).Google Scholar
  12. Jiang, Q., Takemori, A. E., Sultana, M., Porotoghese, P. S., Bowen, W. D., Mosberg, H. I. and Porreca, F., Differential antagonism of opioid delta antinociception by [D-Ala2, Leu5, Cys6]enkephalin and naltrinodole 5′-isothiocyanate: Evidence for delta receptor subtypes.J. Pharmacol. Exp. Ther., 257, 1069–1075 (1991).PubMedGoogle Scholar
  13. Kieffer, B. L., Befort, K., Gaveriaux-Ruff, C. and Hirth, C. G., The d-opioid receptor: Isolation of a cDNA by expression cloning and pharmacological characterization.Proc. Natl. Acad Sci. USA 89, 12048–12052 (1993).CrossRefGoogle Scholar
  14. Koob, G. F. and Bloom, F. E., Cellular and molecular mechanism of drug dependence.Science 242, 715–723 (1988).PubMedCrossRefGoogle Scholar
  15. Lord, J. A. H., Waterfield, A. A., Hughes, J. and Kosterlitz, H. W., Endogeneous opioid peptides: Multiple agonists and receptors.Nature 267, 495–499 (1977).PubMedCrossRefGoogle Scholar
  16. Martin, W. R. and Eades, C. G., Demonstration of tolerance and physical dependence in the dog following a short-term infusion of morphine.J. Pharmacol. Exp. Ther. 133, 262–270 (1966).Google Scholar
  17. Mattia, A., Vanderah, T., Morsberg, H. I. and Porreca, F., Lack of antinociceptive cross-tolerance between [D-Pen2, D-Pen5]enkephalin and [D-Ala2]deltorphin II in mice: Evidence for delta receptor subtypes.J. Pharmacol. Exp. Ther., 258, 583–587 (1991).PubMedGoogle Scholar
  18. Meunier, J. C., Opioid receptors, tolerance and dependence.Therapie 47 (6), 495–502 (1992).PubMedGoogle Scholar
  19. Miyamoto, Y., Portoghese, P. S. and Takemori, A. E., Involvement of δ2 opioid receptors in acute dependence on morphine in mice.J. Pharmacol. Exp. Ther. 265, 1325–1327 (1993).PubMedGoogle Scholar
  20. Negus, S. S., Henriksen, S. J., Mattox, A., Pasternak, G. W., Portoghese, P. S., Takemori, A. E., Weinger, M. G., and Koob, G. F., Effect of antagonist selective for mu, delta and kappa opioid receptors on the reinforcing effects of heroin in rats.J. Pharmacol. Exp. Ther. 265 (3), 1245–1252 (1993).PubMedGoogle Scholar
  21. Nestler, E. J., Erdos, J. J., Terwilliger, R., Duman, R. and Tallman, J. F., Regulation of G proteins by chronic morphine in the rat locus coeruleus.Brain Res. 476, 230–239 (1988).CrossRefGoogle Scholar
  22. North, R. A., Opioid receptor types and membrane ion channels.Trends in Neurosci. 9, 114–117 (1986).CrossRefGoogle Scholar
  23. Raynor, K., Kong, K., Chen, Y., Yasuda, K., Yu, L., Bell, G. and Reisine, T. Pharmacological characterization of the cloned K-, δ-, and μ-opioid receptors.Mol. Pharmacol. 45, 330–334 (1993).Google Scholar
  24. Sambrook, J., Fritsch, E. F. and Maniatis, T.,Molecular cloning. A laboratory manual. 2nd ed. Cold Spring Harbor Laboratory Press., 1989.Google Scholar
  25. Smith, D. B. and Johnson, K. S., Single-step purification of polypeptide expressed inEscherichia coli as fusions with glutathione S-transferase.Gene 67, 31–40 (1988).PubMedCrossRefGoogle Scholar
  26. Sofuoglu, M., Portoghese, P. S. and Takemori, A. E., Differential antagonism of delta opioid agonists by naltrinodole and its benofuran analog (NTB) in mice: Evidence for delta opioid receptor subtypes.J. Pharmacol. Exp. Ther. 257, 676–680 (1991).PubMedGoogle Scholar
  27. Way E. L., Loh, H. H. and Shen, F. H., Simultaneous quantitative assessment of morphine tolerance and physical dependence.J. Pharmacol. Exp. Ther. 167, 1–8 (1969).PubMedGoogle Scholar
  28. Wood, P. L., Charlson, S. E., Lane, D. and Hudgin, R. L., Multiple opioid receptors: Differential binding of μ, and δ agonists.Neuropharmacol. 20, 1215–1220 (1981).CrossRefGoogle Scholar
  29. Yano, I. and Takemori, A. E., Inhibition by naloxone of tolerance an dependence in mice treated acutely and chronically with morphine.Res. Commun. Chem. Pathol. Pharmacol. 16, 721–734 (1977).PubMedGoogle Scholar
  30. Yasuda, K., Raynor, K., Kong, H., Breder, C. D., Takeda, J., Reisine, T. and Bell, G. I., Cloning and functional comparison of opioid receptors from mouse brain.Proc. Natl. Acad. Sci. USA 90, 6736–6740 (1993).PubMedCrossRefGoogle Scholar

Copyright information

© The Pharmaceutical Society of Korea 1995

Authors and Affiliations

  • Ae-Young Kim
    • 1
  • Shee-Yong Lee
    • 1
  • Kyeong-Man Kim
    • 1
  1. 1.Pharmacology Laboratory, College of PharmacyChonnam National UniversityKwang-JuKorea

Personalised recommendations